Medical Literature Monitoring Services

Literature Monitoring in Pharmacovigilance

In the modern pharmaceutical landscape, the systematic and continuous monitoring of medical and scientific literature is an indispensable component of robust pharmacovigilance (PV) practices. Marketing Authorization Holders (MAHs) are mandated by stringent global regulatory authorities—such as the FDA, EMA, and other national bodies—to actively identify, assess, and report suspected adverse reactions found in published scientific papers.
Medical literature serves as a critical, proactive source of safety data that often identifies emerging risks or signals before they appear in spontaneous reporting systems. Failure to maintain a comprehensive and documented literature monitoring process can lead to significant regulatory non-compliance, heavy penalties, and potentially compromise patient safety. Effective surveillance requires a blend of advanced search methodologies, therapeutic expertise, and adherence to evolving international standards like ICH E2E.

Regulatory Standards and Global Compliance Requirements

Ensuring compliance across diverse jurisdictions demands adherence to strict regulatory guidelines regarding the frequency, depth, and documentation of literature searches. Regulatory bodies require that literature reviews cover a wide array of databases to detect Individual Case Safety Reports (ICSRs) and potential safety signals. This process involves the meticulous identification of serious and unexpected adverse events, which must be reported within tight timelines (e.g., 15-day expedited reporting for serious, unexpected events).
Furthermore, the collected safety data must be systematically integrated into aggregate safety reports, such as Periodic Safety Update Reports (PSURs) and Development Safety Update Reports (DSURs), to provide a comprehensive analysis of the drug's risk-benefit profile throughout its lifecycle.

Database Surveillance and Coverage

Comprehensive searching of indexed global databases including PubMed, Embase, and Medline, alongside specialized local journals to ensure exhaustive coverage.

Signal Detection and Management

Implementing robust methodologies to identify emerging safety signals and assess their potential impact on patient safety.

Quality Assurance and Documentation

Maintaining an audit-ready trail of all search strings, screening criteria, assessment decisions, and reporting timelines to ensure full compliance.

Translation of Local Literature

Providing accurate, rapid translation of publications from non-English sources to identify region-specific safety information.

Proregulations' Medical Literature Monitoring Services

We bridge the gap between scientific innovation and regulatory compliance by providing end-to-end literature monitoring solutions tailored to the needs of pharmaceutical innovators. Our team of experts utilizes a combination of advanced technology and scientific rigor to streamline the surveillance process. Our comprehensive services include:

• Strategic search protocol development
  We design and validate product-specific, regulatory-compliant search strings and protocols tailored to your drug's therapeutic area and target markets.
• Automated screening and literature review
  Utilizing cutting-edge AI-driven tools, we automate the initial identification and screening of high volumes of publications, followed by expert manual review to ensure accuracy.
• Comprehensive ICSR identification and reporting
  Our team meticulously reviews identified articles for adverse event data, extracting relevant information and preparing ICSRs for expedited regulatory submission.
• Literature integration for aggregate reporting
  We synthesize findings from literature reviews into comprehensive summaries for PSURs, DSURs, and other safety documents, ensuring data consistency.

If you are looking to enhance your pharmacovigilance framework and ensure robust compliance with global literature monitoring requirements, please feel free to contact us.